Target intelligence / Profile preview

T cell receptor alpha joining 55 (pseudogene) (TRAJ55)

Target
TRAJ55
Molecular classification
Other
01

Overview

T cell receptor alpha joining 55 (TRAJ55) is classified as a pseudogene in humans, meaning it does not encode a functional protein product in the T cell receptor (TCR) complex[2][3]. The T cell receptor genes generally encode components of the TCR complex, which is important for antigen recognition in the adaptive immune response[4]. However, as a pseudogene, TRAJ55 does not contribute an active protein segment to the TCR structure or function. There is no evidence that TRAJ55 serves as a direct therapeutic target, is involved in disease, or interacts with drugs. The designation as a pseudogene indicates its lack of direct biological or clinical significance.

Other names
TRAJ55

Beyond the preview

Go deeper on T cell receptor alpha joining 55 (pseudogene) (TRAJ55).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor alpha joining 55 (pseudogene) (TRAJ55).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call